We are live on ! Find out more
AIC

AWM Investment Company Portfolio holdings

AUM $903M
1-Year Est. Return 163.47%
This Fund
S&P 500
This Quarter Est. Return
+25.65%
1 Year Est. Return
+163.47%
3 Year Est. Return
+487.55%
5 Year Est. Return
+638.08%
10 Year Est. Return
+8,997.75%
AUM
$508M
AUM Growth
+$48.6M
Cap. Flow
-$53.2M
Cap. Flow %
-10.47%
Top 10 Hldgs %
35.46%
Holding
93
New
8
Increased
15
Reduced
28
Closed
8

Top Buys

Rank Stock Value
1
REED
Reeds, Inc. Common Stock
REED
+$5.49M
2
AQMS icon
Aqua Metals
AQMS
+$4.54M
3
TRVN
Trevena, Inc.
TRVN
+$4.33M
4
TGLS icon
Tecnoglass Holdings Inc.
TGLS
+$2.75M
5
LIQT icon
LiqTech
LIQT
+$1.34M

Top Sells

Rank Stock Value
1
LPSN icon
LivePerson
LPSN
+$15.1M
2
MXWL
Maxwell Technologies Inc
MXWL
+$9.81M
3
LOXO
Loxo Oncology, Inc
LOXO
+$9.8M
4
AXGN icon
Axogen
AXGN
+$4.55M
5
KIDS icon
OrthoPediatrics
KIDS
+$4.24M

Sector Composition

Rank Sector Weight
1 Technology 39.61%
2 Healthcare 20.68%
3 Industrials 13.14%
4 Consumer Discretionary 9.81%
5 Consumer Staples 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZEAL
76
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$340K 0.07%
19,981
– –
TPST icon
77
Tempest Therapeutics
TPST
$18.9M
$300K 0.06%
103
– –
IMMR icon
78
Immersion
IMMR
$248M
$180K 0.04%
21,309
-16,587
-44% -$152K
SRTSW
79
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
$65K 0.01%
130,261
-364,678
-74% -$332K
CLRB icon
80
Cellectar Biosciences
CLRB
$21.1M
$11K ﹤0.01%
355
– –
EYEGW
81
DELISTED
Eyegate Pharmaceuticals, Inc. Warrants
EYEGW
$3K ﹤0.01%
137,092
– –
AXGN icon
82
Axogen
AXGN
$2.61B
– –
-222,500
Closed -$4.55M
DMRC icon
83
Digimarc Corp
DMRC
$172M
– –
-43,772
Closed -$635K
ECOR icon
84
electroCore
ECOR
$82.2M
– –
-17,951
Closed -$1.68M
AMRS
85
DELISTED
Amyris Inc.
AMRS
– –
-504,250
Closed -$1.68M
ASPU
86
DELISTED
ASPEN GROUP, INC.
ASPU
– –
-464,156
Closed -$2.54M
BFRA
87
DELISTED
Biofrontera AG American Depositary Shares
BFRA
– –
-302,418
Closed -$3.54M
LOXO
88
DELISTED
Loxo Oncology, Inc
LOXO
– –
-70,000
Closed -$9.8M
DTRM
89
DELISTED
Determine, Inc. Common Stock
DTRM
– –
-1,455,220
Closed -$335K
1 2 3
4

Similar funds

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AOWM
Asset One Wealth Management Bellevue, Washington $904M AUM
EI
EnCap Investments Houston, Texas $905M AUM
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
PSCM
Per Stirling Capital Management Austin, Texas $905M AUM 17.06% 1-Year Est. Return
HIGP
Hill Investment Group Partners St. Louis, Missouri $906M AUM 20.13% 1-Year Est. Return
GGH
GCM Grosvenor Holdings Chicago, Illinois $901M AUM 28.6% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

AWM Investment Company's Q1 2019 Portfolio in Review

As of Q1 2019, AWM Investment Company held 93 positions worth $508M, up 11% from $459M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AWM Investment Company withdrew a net $53.2M in Q1 2019, closing 8 positions and reducing 28 holdings. Its most notable exit was Loxo Oncology, Inc, an estimated $9.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 41% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AWM Investment Company opened a new position in Trevena, Inc. worth $5.62M.

  • AWM Investment Company's largest Q1 2019 buy was Trevena, Inc.: 5,760 shares worth $5.62M.
  • AWM Investment Company added most to Reeds, Inc. Common Stock in Q1 2019, an estimated $5.49M increase.
  • AWM Investment Company's biggest Q1 2019 reduction was LivePerson, cutting an estimated $15.1M.
  • AWM Investment Company fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $9.8M.
  • AWM Investment Company's ten largest holdings make up 35% of its $508M portfolio in Q1 2019.
  • AWM Investment Company opened 8 new positions and closed 8 in Q1 2019.
  • AWM Investment Company's portfolio value rose 11% quarter-over-quarter to $508M.

Based on AWM Investment Company's 13F filing for Q1 2019, filed 14 May 2019.